N&V Editorial: Physical Medicine and Rehabilitation is Empowerment Medicine
News&Views Issue 60 Editorial by André Thevenon This issue of News and Views contains the results of a French nationwide survey of the perception of…
Category: News & Announcements
We’ll Meet Again
By André Thevenon The regression of the COVID pandemic allowed a gradual resumption of PRM congresses worldwide. Last Autumn, while the AAPM&R annual assembly was…
How are French PMR physicians viewed by their colleagues?
By Emmanuelle Prelot, Franck Rolland, Evan Gouy, Linh-Nam Truong, Ariel Frajerman, Florent Vinchon, Nawale Hadouiri (nawale.hadouiri@chu-dijon.fr) On behalf of the French National Association of Residents…
TRANSCRANIAL DIRECT CURRENT STIMULATION FOR OSTEOARTHRITIS AND NEUROTROPHIC FACTOR
Article of the Month by David Burke While the main symptom of osteoarthritis (OA) is peripheral pain, central sensitization mechanisms are also implicated. Transcranial direct…
New Abstract Deadline for ISPRM2022
Dear Colleagues, Dear Friends, With the improving COVID-19 situation, increasing vaccination, and the easing of global travel restrictions, we are thrilled to host an in-person ISPRM2022/ESPRM2022…
ISPRM 2022 Elections: President’s Cabinet
ISPRM is collecting nominations for 3 leadership positions to be elected at the upcoming conference in Lisbon (isprm2022.com). Vice President Secretary Treasurer PLEASE read carefully each position…
ISPRM 2022 Awards: OPEN for Nominations
ISPRM will present various awards at the upcoming conference in Lisbon (isprm2022.com). Would you like to have your efforts in the field of PRM recognized by…
ISPRM President – 2022 Message
New Year Greetings from the President Wish you all a Happy and Healthy Year of 2022 and Chinese New Year of Tiger. The world is…
Consolidated Statements on Rehabilitation to the WHO
During the World Health Organization (WHO) EXECUTIVE BOARD MEETING 24– 29 January 2022, ISPRM joined a coalition of rehabilitation-focused organisations & networks to deliver the…
ATOGEPANT FOR THE PREVENTION OF MIGRAINES
Article of the Month by David Burke Monoclonal antibodies that target calcitonin gene–related peptide (CGRP) have been introduced to reduce onset of migraines. Atogepant is…